FDA Decision and Its Implications Details on the FDA Ruling On February 21, 2025, the FDA announced that semaglutide has been removed from its drug shortage list after determining that supply levels of Ozempic and Wegovy are now stable
Follow-Up: We schedule follow-ups to ensure your satisfaction and tweak results if needed
Abstract The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an unprecedented global health crisis
This genetic analysis examines your GLP-1 receptor (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants, revealing how your body processes peptide-based therapies and metabolizes nutrients
Read more about this decision
For GHK-Cu, the strongest human evidence is in wound healing, diabetic ulcer treatment, and hair loss (multiple randomized trials in androgenetic alopecia)